![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Clinical characteristics used for machine learning identification of fast progressors among patients with NASH
|
|
|
AASLD 2020 Nov 11-16
Brenda Reinhart1, Matt Docherty2, Maria-Magdalena Balp3, Andreas Tietz3, Jennifer Cai4, Sanchita Porwal5, Carolle Kinyua6, Marcos C Pedrosa3, Jorn M Schattenberg7
1ZS Associates, Zurich, Switzerland; 2ZS Associates, Princeton, USA; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Pharmaceuticals Inc, East Hanover, USA; 5ZS Associates, London, UK; 6Novartis South Africa (Pty) Ltd, Waterfall City, South Africa; 7Department of Medicine, University Medical Center Mainz, Germany
![1124201](../images/112420/112420-4/1124201.gif)
![1124202](../images/112420/112420-4/1124202.gif)
![1124203](../images/112420/112420-4/1124203.gif)
![1124204](../images/112420/112420-4/1124204.gif)
![1124205](../images/112420/112420-4/1124205.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|